Steven Cohen Jazz Pharmaceuticals PLC Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 182,015 shares of JAZZ stock, worth $23.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

182,015

Previous 182,015 -0.0%

Holding current value

$23.2 Million

Previous $19.4 Million -0.0%

% of portfolio

0.05%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $18.9 Million - $21.7 Million	182,015 New	182,015 $19.4 Million
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $7.88 Million - $9.39 Million	64,624 New	64,624 $8.36 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $10.2 Million - $12.2 Million	76,109 Added 644.99%	87,909 $12.9 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $49.3 Million - $60.8 Million	-380,100 Reduced 96.99%	11,800 $1.88 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $12.5 Million - $15.9 Million	98,631 Added 33.63%	391,900 $52.2 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $25.9 Million - $30.8 Million	-182,905 Reduced 38.41%	293,269 $45.8 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $63.2 Million - $78.4 Million	-487,650 Reduced 50.6%	476,174 $74.1 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $25.7 Million - $31.2 Million	214,524 Added 28.63%	963,824 $123 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $96.4 Million - $138 Million	749,300 New	749,300 $97.6 Million
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $45.9 Million - $53.9 Million	-326,289 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $2.09 Million - $2.86 Million	-19,850 Reduced 5.73%	326,289 $46.5 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $30.9 Million - $39.4 Million	323,439 Added 1424.84%	346,139 $38.2 Million
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $1.99 Million - $3.47 Million	22,700 New	22,700 $2.26 Million
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $25.5 Million - $33.4 Million	-216,943 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$125.18 - $143.24 $27.2 Million - $31.1 Million	216,943 New	216,943 $27.8 Million
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $5.64 Million - $6.32 Million	-35,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $2.19 Million - $2.75 Million	-15,000 Reduced 30.0%	35,000 $6.03 Million
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $6.78 Million - $7.86 Million	50,000 New	50,000 $7.55 Million
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $9.79 Million - $11.2 Million	-74,700 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $10.7 Million - $11.6 Million	74,700	74,700 $10.9 Million

Others Institutions Holding JAZZ

# of Institutions

507

Shares Held

55.7M

Call Options Held

170K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account